Ramayanti, O.; Brinkkemper, M.; Verkuijlen, S.A.W.M.; Ritmaleni, L.; Go, M.L.; Middeldorp, J.M.
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas. Cancers 2018, 10, 89.
https://doi.org/10.3390/cancers10040089
AMA Style
Ramayanti O, Brinkkemper M, Verkuijlen SAWM, Ritmaleni L, Go ML, Middeldorp JM.
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas. Cancers. 2018; 10(4):89.
https://doi.org/10.3390/cancers10040089
Chicago/Turabian Style
Ramayanti, Octavia, Mitch Brinkkemper, Sandra A. W. M. Verkuijlen, Leni Ritmaleni, Mei Lin Go, and Jaap M. Middeldorp.
2018. "Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas" Cancers 10, no. 4: 89.
https://doi.org/10.3390/cancers10040089
APA Style
Ramayanti, O., Brinkkemper, M., Verkuijlen, S. A. W. M., Ritmaleni, L., Go, M. L., & Middeldorp, J. M.
(2018). Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas. Cancers, 10(4), 89.
https://doi.org/10.3390/cancers10040089